Exchange-traded fund (ETF) flows aren't always as revealing as some investors believe. For example, a stock-based ETF can be beset by departures, but if the fund's underlying holdings increase in value, the ETF's price rises. Perpetual futures competition is weighing on Hyperliquid (CRYPTO: HYPE) ETF flows.
ETFs dedicated to a specific cryptocurrency are different animals because, at least in theory, market participants buy them to express bullish views. Conversely, they sell to take profits or because their positive views weren't validated. This Rare Signal Is Flashing Again.
In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue » That makes the recent goings-on in the Hyperliquid space, an infant corner of the cryptocurrency ETF realm, interesting.
The Grayscale Hyperliquid Staking ETF (NASDAQ: HYPG), the largest ETF in an admittedly small group, and its two primary competitors got off to solid starts, but that momentum evaporated. Let's explore why that's the case and why Hyperliquid's direct owners shouldn't overlook the situation. To the credit of the Grayscale fund, the Bitwise Hyperliquid ETF (NYSEMKT: BHYP), and the 21Shares Hyperliquid ETF (NASDAQ: THYP), these funds got off to fine starts.
The latter two debuted in May and now combine for more than $150 million in assets under management (AUM), while the Grayscale ETF is closing in on $113 million in AUM despite being barely more than two months old. Those are impressive tallies given the funds' ages and the intense competition in the crypto ETF arena. Speaking of competition, that's what reversed the Hyperliquid ETF flows.
Hyperliquid is the dominant decentralized protocol for the trading of perpetual futures (perps). In the first quarter of 2026, this digital asset was the currency of choice for more than $633 billion in perps volume. Much of the related fees went toward Hyperliquid token buybacks, acting as a supply suppressant.
Extract — continue reading at the source.
